Business

Amendment: Director/PDMR Shareholding

Amendment: Director/PDMR Shareholding.

articleOxford Biodynamics PlcSeptember 1, 20235/company/oxford-biodynamics-plc/news/amendment-directorpdmr-shareholding
Amendment: Director/PDMR Shareholding

About this update from Oxford Biodynamics Plc

[{"type":"text","content":"\n\n \nOxford BioDynamics PLC\nAmendment: Director/PDMR Dealings\n1 September 2023 - Oxford, UK - Oxford BioDynamics PLC (AIM: OBD, \"OBD\" or the \"Company\"), a biotechnology company developing precision medicine tests based on the EpiSwitch® 3D genomics platform, announces that it has received notice from Vulpes Investment Management Pte Ltd (\"Vulpes\") that on 26 January 2023 the Vulpes Testudo Fund purchased 443,673 Ordinary Shares of 1 pence each (\"Ordinary Shares\") at an average price of 14.75p rather than 343,673 Ordinary Shares of 1 pence each (\"Ordinary Shares\") at an average price of 14.7p as previously announced.\nTherefore, Vulpes is currently interested in 28,448,756 shares in total. Vulpes is controlled by Non-Executive Director, Stephen Diggle, who is therefore deemed to be interested in a total of 28,448,756 shares, representing approximately 14.06% of the Company's current issued share capital.\nThe corrected notification below, made in accordance with the requirements of UK Market Abuse Regulation, provides further details:\n\n\n\n1\n\n\nDetails of the person discharging managerial responsibilities / person closely associated\n\n\n\n\na) \n\n\nName\n\n\nStephen Diggle\n\n\n\n\n2\n\n\nReason for the notification\n\n\n\n\na)\n\n\nPosition/status\n\n\nDirector/PDMR\n\n\n\n\nb)\n\n\nInitial notification /Amendment\n\n\nAmendment\n\n\n\n\n3\n\n\nDetails of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor\n\n\n\n\na)\n\n\nName\n\n\nOxford BioDynamics Plc\n\n\n\n\nb)\n\n\nLEI\n\n\n2138005Y1TK258O5U928\n\n\n\n\n4\n\n\nDetails of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted\n\n\n\n\na)\n \n\n\nDescription of the financial instrument, type of instrument\n Identification code\n \n\n\nOrdinary Shares of 1p par value each\n  \nISIN: GB00BD5H8572\n\n\n\n\nb)\n\n\nNature of the transaction\n\n\nPurchase of Ordinary Shares\n\n\n\n\nc)\n \n\n\nPrice(s) and volume(s)\n\n\n \n\n\n\n Price(s)\n\n\nVolume(s)\n\n\n\n\n£0.148\n\n\n100,000\n\n\n\n\n£0.148\n\n\n143,673\n\n\n\n\n£0.147\n\n\n200,000\n\n\n\n\n\n\n\n\nd)\n \n\n\nAggregated information\n- Aggregated volume\n- Price\n\n\n \n4...

More updates from Oxford Biodynamics Plc